Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 62 USD -0.63% Market Closed
Market Cap: 3.9B USD

Intrinsic Value

The intrinsic value of one RYTM stock under the Base Case scenario is 59.45 USD. Compared to the current market price of 62 USD, Rhythm Pharmaceuticals Inc is Overvalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RYTM Intrinsic Value
59.45 USD
Overvaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Rhythm Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for RYTM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare RYTM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RYTM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Rhythm Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rhythm Pharmaceuticals Inc

Current Assets 369.3m
Cash & Short-Term Investments 314.5m
Receivables 17.8m
Other Current Assets 37m
Non-Current Assets 17.4m
PP&E 3.8m
Intangibles 6m
Other Non-Current Assets 7.6m
Efficiency

Free Cash Flow Analysis
Rhythm Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rhythm Pharmaceuticals Inc

Revenue
162.8m USD
Cost of Revenue
-17m USD
Gross Profit
145.8m USD
Operating Expenses
-458.3m USD
Operating Income
-312.5m USD
Other Expenses
-2.9m USD
Net Income
-315.4m USD
Fundamental Scores

RYTM Profitability Score
Profitability Due Diligence

Rhythm Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
34/100
Profitability
Score

Rhythm Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

RYTM Solvency Score
Solvency Due Diligence

Rhythm Pharmaceuticals Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
63/100
Solvency
Score

Rhythm Pharmaceuticals Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 85.09 USD with a low forecast of 72.72 USD and a high forecast of 98.7 USD.

Lowest
Price Target
72.72 USD
17% Upside
Average
Price Target
85.09 USD
37% Upside
Highest
Price Target
98.7 USD
59% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Rhythm Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RYTM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RYTM Insider Trading
Buy and sell transactions by insiders

RYTM News

Other Videos
What is the Intrinsic Value of one RYTM stock?

The intrinsic value of one RYTM stock under the Base Case scenario is 59.45 USD.

Is RYTM stock undervalued or overvalued?

Compared to the current market price of 62 USD, Rhythm Pharmaceuticals Inc is Overvalued by 4%.

Back to Top